Irisin significantly alleviated inflammasome signaling, AGE-induced oxidative stress, endothelial dysfunction, and increased eNOS and NO production in a dose-dependent manner, thus demonstrating the Irisin–AGE interplay [110]. Here, FNDC5 is linked to endothelial dysfunction.